Joshua Deignan

Dr. Joshua Deignan specializes in molecular genetics and genomics, serving as an Associate Clinical Professor in the Department of Pathology and Laboratory Medicine at UCLA's David Geffen School of Medicine. With a profound dedication to advancing the field of molecular diagnostics, he also holds the position of Associate Director at the UCLA Molecular Diagnostics Laboratories. His academic journey began with a PhD in Pathology, followed by a comprehensive medical genetics fellowship training at UCLA, equipping him with a robust foundation in genetic research and clinical applications. Dr. Deignan's expertise is further validated by his board certification from the American Board of Medical Genetics and Genomics in Clinical Molecular Genetics and Genomics. His research interests are deeply rooted in the exploration of molecular genetics and genomics, where he has contributed significantly to the understanding and application of these disciplines in clinical settings. His work often involves the integration of cutting-edge genomic technologies to improve diagnostic accuracy and patient outcomes. Throughout his career, Dr. Deignan has been actively involved in numerous research projects and collaborations, aiming to bridge the gap between laboratory discoveries and clinical practice. His contributions to the field are reflected in his numerous publications and presentations at national and international conferences, where he shares his insights and findings with the broader scientific community. In addition to his research and clinical responsibilities, Dr. Deignan is committed to education and mentorship, guiding the next generation of scientists and clinicians in the rapidly evolving field of molecular genetics. His dedication to teaching is evident in his involvement with various educational programs at UCLA, where he inspires students and trainees to pursue excellence in their academic and professional endeavors. Dr. Deignan's work continues to have a significant impact on the field of molecular diagnostics, as he strives to enhance the understanding and treatment of genetic disorders through innovative research and clinical practice. His contributions are instrumental in shaping the future of personalized medicine, making him a respected leader and visionary in his field.